Congenital deficiency of the proprotein convertase subtilisine/kexin type 1 gene (PCSK1), which encodes proprotein convertase 1/3, causes a severe multihormonal disorder marked by early-onset obesity. The single nucleotide polymorphisms (SNPs) rs6232 and rs6234-rs6235 in PCSK1 have been associated with obesity. However, case-control studies carried out in populations of different ethnicities have only partly replicated this association. Moreover, these SNPs have only weakly been associated with body mass index (weight (kg)/height (m) 2 ) at a genome-wide level of significance. To investigate this discrepancy, we conducted a systematic search for studies published before December 2013 and extracted relevant data. Pooled estimates were calculated for overall and subgroup analyses. This meta-analysis confirmed the association of PCSK1 SNPs with obesity and provides the first evidence that the association between PCSK1 rs6232 and obesity is stronger for childhood obesity than for adult obesity. Moreover, we identified weak associations with body mass index and significantly stronger associations with waist circumference for rs6234-rs6235. No difference was found in the association with different obesity grades, and no association of PCSK1 rs6234-rs6235 with obesity was identified in Asian populations. This systematic Human Genome Epidemiology (HuGE) review showed convincingly that the SNPs rs6232, rs6234, and rs6235 in PCSK1 are associated with obesity in Caucasians.
PCSK1 has also been implicated in glucose homeostasis, proinsulin disorders, fat oxidation, and postabsorptive resting energy expenditure (4) (5) (6) (7) (8) (9) (10) . In 1997, the case of a patient with congenital PCSK1 deficiency and severe obesity was reported (2) . Since then, several other patients with congenital PCSK1 deficiency have been identified. The patients with congenital PCSK1 deficiency were all born full-term with a normal birth weight (2, (11) (12) (13) (14) (15) (16) . Shortly after birth, the infants began to experience metabolic acidosis, dehydration, and diarrhea. The majority of the patients survived only with total parenteral nutrition. In midchildhood (around age 6 years), the dependency on parenteral feeding decreased, diarrhea diminished, and patients showed hyperphagia, polydipsia, polyuria, and rapid weight gain (13) . This multihormone dysfunction further included hypocortisolism, growth hormone deficiency, postprandial hypoglycemia, hypogonadism, and reduced thyroid function. In different animal species, functional single nucleotide polymorphisms (SNPs) in PCSK1 orthologs have been found to be associated with fat deposition and growth traits (17) (18) (19) (20) (21) .
In 2008, Benzinou et al. (22) reported on the association of 3 SNPs-rs6232, rs6234, and rs6235-with obesity, of which rs6234 and rs6235 were shown to be in strong linkage disequilibrium. Odds ratios were reported as 1.34 and 1.22 for rs6232 and the SNP pair rs6234-6235, respectively. Since then, other case-control studies have been conducted in cohorts of European, Mexican, North American, and Asian descent (23) (24) (25) (26) . The initial findings by Benzinou et al. (22) were only partially replicated. With the start of the genomewide association study era, multiple studies were conducted in European, Asian, and African populations (21, (27) (28) (29) (30) . Several SNPs were identified as contributing to body mass index (BMI; weight (kg)/height (m) 2 ), but PCSK1 SNPs were only marginally associated with BMI (31, 32) .
In order to obtain insight into this discrepancy, it is important to look for variables in study design that might have influenced the association between PCSK1 variants and obesity. In this study, we assessed the association of the PCSK1 SNPs rs6232 and rs6234-rs6235 with obesity and with quantitative traits, such as BMI and waist circumference (WC). To address this question, we undertook a systematic Human Genome Epidemiology (HuGE) review and meta-analysis of the present literature. Using meta-regression and subgroup analysis, we aimed to identify populations at risk, in which carriers of the minor alleles have increased risk of obesity.
METHODS

Search strategy
We performed a sensitive search in order to find both published and unpublished records. The electronic databases Medline (US National Library of Medicine, Bethesda, Maryland), Web of Science (Thomson Reuters Corporation, New York, New York), and Embase (Excerpta Medica, Elsevier B.V., Amsterdam, the Netherlands) were searched with the following query, which combines a Medical Subject Headings (MeSH) term with free text: "prohormone convertase 1" OR "PCSK1" OR "PC1/3" OR "proprotein convertase 1" OR "Proprotein Convertase 1" [MeSH] . The final search was conducted on November 27, 2013. Additionally, using Web of Science, we screened for articles which referred to or shared references with the paper by Benzinou et al. (22) . Full articles, congress proceedings, and reference lists were checked for novel information.
Inclusion criteria
The following requirements were set for the inclusion of studies: 1) The study had a case-control design for obese versus lean individuals or reports on quantitative traits of BMI or WC; 2) the study was not a family-based association study; 3) obesity was defined according to the WHO cutoffs for BMI (33, 34) ; 4) the study reported on rs6232, rs6234, or rs6235 in humans; 5) complete information was available or was personally provided by the study investigators; and 6) for different studies reporting on the same cohorts, only the most complete and largest cohorts were used.
Quality appraisal
The quality of each study was critically assessed using the Strengthening the Reporting of Genetic Association Studies (STREGA) statement (35) . The following aspects of each study were appraised: genotyping procedures and quality control, description of the study cohort, case-control matching, adjustment for covariates, adjustment for multiple comparisons, reporting of statistical methods, reporting of genotype frequency per case/control group, reporting of cohort characteristics for cases and controls separately, and reporting of departure from Hardy-Weinberg equilibrium.
Data collection and extraction
The following data were extracted in a standardized manner by 2 of the authors (P.S. and K.T.) independently: first author and publication year, included case/control cohorts, effect size per cohort, number of participants per cohort, genetic model used, ethnicity, average age of the case cohort or calculated average age, and average BMI or obesity grade according to WHO definitions (33, 34) . For the quantitative traits BMI and WC, β coefficients and measures of error (standard error or 95% confidence interval) were extracted. Ethnicity was categorized as Caucasian, African-American, Asian, or Hispanic. On the basis of nationality, Mexicans were categorized as Hispanic; Taiwanese and Chinese persons were categorized as Asian; and North American whites and European populations were categorized as Caucasian. African Americans were categorized as such. When average BMI was available, it was categorized into 3 obesity grades (grade I: 30-<35; grade II: 35-<40; grade III: ≥40) according to the WHO definitions (33) . For Asians, there is no clear consensus on appropriate obesity cutoff values because of large ethnic heterogeneity. Therefore, both BMI ≥27 and BMI ≥28 were accepted as cutoffs. When information on average age was not available, this was calculated from the supplementary data. Cohorts were considered childhood cohorts when the average age was less than 18 years. Both the 95th and 97th percentiles were accepted as obesity cutoffs for childhood cohorts.
Data analysis
The selected studies were partitioned into their constituent cohorts to allow for subgroup analysis and meta-regression. The data were analyzed for rs6232 and rs6234-rs6235 separately. Data on rs6234 or rs6235 were combined, because these SNPs are reported to be in very high linkage disequilibrium in all investigated ethnic groups (Caucasians: r 2 > 0.96 (22) ; African Americans and Hispanics: r 2 > 0.76 (23) ; Chinese Han population: r 2 > 0.98 (36) ). Considering the heterogeneity in the study populations and study methods, we used the restricted maximum likelihood random-effects model to calculate summary effects for the association, subgroup, and regression analyses. Recently it has been shown that the restricted maximum likelihood random-effects model performs better than the more popular DerSimonian and Laird model (37) . The heterogeneity of the studies was investigated using the Q statistic (Q difference, I
2 ), where I 2 values between 25% and 50% were considered to indicate moderate heterogeneity and values higher than 50% were considered to indicate high heterogeneity (38) .
When more than 10 cohorts were included in 1 analysis, we performed meta-regression using the log odds ratio as the dependent variable and average age as the independent variable. Regression was tested using z statistics (omnibus test for intercept and coefficient), and a bubble plot was generated. In addition, subgroup analysis was performed when the subgroup contained at least 4 cohorts. Subgroup analyses were performed for ethnicity, obesity grade, and adult obesity versus childhood obesity. Differences between subgroups were tested using the Q statistic for heterogeneity (39) . Publication bias was investigated with Begg's funnel plot, using cohort-specific effect sizes for the association, and asymmetry was assessed formally using Egger's test and the rank correlation test (40) .
We conducted sensitivity analyses by excluding the appraised study that had the lowest quality and that did not report on Hardy-Weinberg equilibrium for PCSK1 variants. A sensitivity analysis could also include studies that were judged to cause abnormal heterogeneity. Statistical analyses were performed with OpenMeta[Analyst] software (Center for Evidence-based Medicine, Brown University School of Public Health, Providence, Rhode Island) (41) and R 3.02 software (R Foundation for Statistical Computing, Vienna, Austria) (42) using the metafor package (versions 1.9 and 2) (43). Odds ratios and 95% confidence intervals were calculated.
Assessment of cumulative evidence
The Venice criteria for measuring the credibility of cumulative evidence were applied to assess the strength of the evidence of genetic association (44) . Results from the pooled analyses were rated for amount of evidence, extent of replication, and protection from bias. For each category, one of 3 grades was given: "A," strong; "B," moderate; or "C," weak. Epidemiologic evidence was considered strong when all 3 grades were "A," moderate when grades included at least 1 "B" (but no "C"), and weak if any grade was "C." In practice, we rated the amount of evidence based upon the value of the product n minor = (minor allele frequency × no. of cases). If n minor > 1,000, the evidence was rated A; if n minor > 100, the evidence was rated B; and if n minor < 100, the evidence was rated C. I 2 values served as an indication of replication. I 2 values close to 25% were considered to indicate low heterogeneity; values around 50% were considered to indicate moderate heterogeneity; and values around 75% were considered to indicate high heterogeneity. Ratings were given accordingly. Protection from bias was rated, taking into account the results of the sensitivity analyses and the quality appraisal process.
RESULTS
For the systematic search, we searched common electronic databases for references published before November 27, 2013, using a broad query, and reference lists were checked for unique citations (Figure 1) Figure 1 . Search strategy used to select articles published before December 2013 for a review and meta-analysis of associations between the proprotein convertase subtilisin/kexin type 1 gene (PCSK1) single nucleotide polymorphisms (SNPs) rs6232 and rs6234-rs6235 and obesity, body mass index (BMI), and waist circumference. In the first stage, search results were screened for records about PCSK1 in humans. In the second stage, duplicate studies were removed. Studies not reporting on the SNPs rs6232, rs6234, and rs6235 were removed. Finally, 20 studies were assessed for eligibility, and 19 were included in the analyses. The selection of studies was carried out by 2 independent reviewers (P.S. and K.T.), and disagreements were resolved through discussion.
674 records in Embase, 531 records in Medline, and 222 records in Web of Science. Reference lists contained information that allowed us to retrieve another 109 references. Abstracts were screened for relevancy, and duplicate studies were excluded; this yielded 52 studies about PCSK1 in humans. Full texts were assessed, and studies that did not report on the PCSK1 SNPs were excluded. Finally, 21 unique studies were identified, of which 1 was excluded because it did not report on the SNPs within the context of obesity, BMI, or WC. The extensive literature search yielded 20 studies which were eligible for inclusion (Table 1) . Fifteen studies reported on obesity risk, 11 studies reported on associations with BMI, and 5 studies reported on associations with WC. (26) were found to contain overlapping cohorts regarding the association with obesity risk. The smaller cohorts were excluded from these studies ( Table 2) . For the Northern Sweden Health and Disease Study cohort (Renström et al. (65)), novel data were acquired from investigators in the larger Gene × Lifestyle Interactions and Complex Traits Involved in Elevated Disease Risk (GLACIER) Study (45) . For the analysis of obesity risk, only part of this cohort could be used because of overlap with data from the study by Berndt et al. (32) . The included studies and their constituent cohorts are listed in Tables 3 and 4 . The quality of each study was appraised using the criteria of the STREGA statement (Table 5 ) (35) . In 4 studies, the investigators did not mention whether duplicate samples were analyzed as a control for genotyping, and Dušátková et al. (46) (67) did not report participants' characteristics by genotype. In 7 studies, 5 of which were population-based, investigators did not report cohort characteristics for cases and controls separately. The 2 remaining studies contributed only to quantitative trait analyses, not to meta-analyses of obesity risk. All studies adjusted P values for the covariates sex and age, while some adjusted for additional covariates. Some studies neither adjusted for multiple comparisons nor reported genotypes per case/control group (Table 5) . Overall, Dušátková et al. (46) scored the lowest on the quality appraisal criteria, and Xi et al. (30) did not report on HardyWeinberg equilibrium. Consequently, both studies were included in a sensitivity analysis (see Web Table 1 , available at http://aje.oxfordjournals.org/). It is possible that investigators in some studies did take these measures into account but did not report it.
We performed an extensive search for unpublished data using different electronic databases and reference lists to minimize publication bias. In addition, Begg's funnel plots were generated for the published associations of both SNPs with obesity risk (Web Figure 1) . For rs6234-rs6235, there was no indication of plot asymmetry visually or according to Egger's test (P = 0.54) or the rank correlation test (P = 0.60). For rs6232, Egger's test and the rank correlation test gave contradicting results (P = 0.004 and P = 0.68) (40, 47) . For the association of rs6232 and rs6234-rs6235 with quantitative traits, there were no indications of publication bias according to Egger's test or the rank correlation test (P > 0.05).
Meta-analyses of the association of PCSK1 SNPs with obesity risk
The meta-analysis that included all cohorts showed that both rs6232 and rs6234-rs6235 were significantly associated with obesity status (odds ratio (OR) = 1.19 (95% confidence interval (CI): 1.09, 1.29) and OR = 1.09 (95% CI: 1.04, 1.13), respectively) (Tables 6 and 7 ). Heterogeneity was considerable for both meta-analyses (rs6232: I 2 = 50%; rs6234-rs6235: I 2 = 65%) ( Tables 6 and 7 , Web Figure 2 ).
Subgroup meta-analysis according to obesity severity
The case-control study design enriches the sample for severe phenotypes, in contrast to population samples. This could render the case-control design more sensitive to finding associations (48) . We assessed whether the association within our meta-analysis was dependent on obesity severity, using the classification defined by the WHO (33, 34) . In adult cohorts, the association was tested for the 3 obesity grades (Web Figure 3 , Tables 6 and 7) . For this analysis, we excluded the Mexican adult obesity grade I/II cohort, since it was not clear how to categorize obesity in this cohort. There was a strong association of rs6232 with obesity grade I (OR = 1.09, 95% CI: 1.02, 1.16) but not with grade II (OR = 1.16, 95% CI: 0.91, 1.49) or grade III (OR = 1.21, 95% CI: 0.84, 1.74) ( Table 6 ). The absence of an association with obesity grade II could be explained by the limited number of studies and the low accuracy of the studies. The absence of association in the most severe obesity grade, grade III, could be explained by the high level of heterogeneity (I 2 = 78%), which was driven by the negative association in the Swiss cohort of obese adults (Web Figure 3) . Upon closer investigation of this cohort, described by Meyre et al. (31), we noted that of the limited number of controls (n = 320), no homozygous individuals were present. Within an additive genetic model, this can lead to severe bias. Therefore, we performed a sensitivity analysis, replacing this cohort with the Swiss participant sample described by Benzinou et al. (22) , which was drawn from the same overall cohort (49) . Replacement of the cohort reduced the heterogeneity to 32% and induced a significant association between class III obesity and rs6232 (OR = 1.33, 95% CI: 1.10, 1.61) (Web Table 2 ). However, in neither of the 2 meta-analyses was there a difference in the association according to obesity grade (P = 0.12 and P = 0.43).
The SNP pair rs6234-rs6235 was significantly associated with all obesity grade subgroups, but the association did not vary across subgroups (P = 0.57) ( Table 7 , Web Figure 3 ). The replacement of the Swiss cohort did not induce a significant difference in the associations of rs6234-rs6235 with the different obesity grade subgroups (P = 0.12) (Web Table 2 ). There was, however, a significant difference between the obesity grade I and obesity grade III subgroups (P = 0.04).
The categorization of the cohorts into obesity grade subgroups resulted in a loss of information, and this could have produced less sensitive analyses. Therefore, in addition to the previous analyses, we conducted meta-regression analysis for the mean BMIs of the investigated cohorts. This showed that with increasing cohort BMI, rs6234-rs6235 was more strongly associated with obesity (P = 0.02), but this was not true for rs6232 (P = 0.4).
Subgroup meta-analysis according to average age Kilpeläinen et al. (26) observed an association with obesity only in cohort members under 59 years of age. To investigate whether age has an influence on the association, we divided the cohorts into childhood obesity cohorts and adult cohorts. Subgroup analysis showed that the association with obesity was stronger in childhood cohorts than in adult cohorts for rs6232 (for childhood cohorts, OR = 1.43, 95% CI: 1.19, 1.73; (44): Evidence was considered strong when all 3 grades were "A," moderate when grades included at least 1 "B" (but no "C"), and weak if any grade was "C."
b Significant heterogeneity (P < 0.05). c P values were obtained from the Q test for heterogeneity. d Weight (kg)/height (m) Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds ratio; PCSK1, proprotein convertase subtilisin/kexin type 1 gene. a Venice criteria for the strength of cumulative epidemiologic evidence (44): Evidence was considered strong when all 3 grades were "A," moderate when grades included at least 1 "B" (but no "C"), and weak if any grade was "C."
b Significant heterogeneity (P < 0.05). c P values were obtained from the Q test for heterogeneity.
for adult cohorts, OR = 1.11, 95% CI: 1.05, 1.18; P = 0.03) but not for rs6234-rs6235 (childhood: OR = 1.15, 95% CI: 0.98, 1.36; adult: OR = 1.08, 95% CI: 1.04, 1.11; P = 0.41) (Web Figure 2, Tables 6 and 7) . The absence of a significant association of rs6234-rs6235 with childhood obesity and the absence of a difference in the associations with obesity between childhood and adult cohorts might be due to the large heterogeneity in the childhood subgroup ðI 2 ¼ 78%), whereas for rs6232, heterogeneity within subgroups was low ðchildhood: I 2 ¼ 33%; adult: I 2 ¼ 12%). To investigate whether the association also correlated with age within the adult cohorts, we performed meta-regression analysis for age. Neither of the associations with obesity correlated with adult age (for rs6232, P = 0.5; for rs6234-rs6235, P = 0.1).
Subgroup meta-analysis according to ethnicity
For rs6232, we analyzed the association with obesity for Hispanic cohorts and Caucasian cohorts separately. We found an association with obesity in the Caucasian population (OR = 1.17, 95% CI: 1.09, 1.27) but not in the Hispanic population (OR = 1.50, 95% CI: 0.65, 3.48) ( Table 6 ). For rs6234-rs6235, subgroup analyses showed that the combined SNPs were not associated with obesity in the Asian population (OR = 1.01, 95% CI: 0.90, 1.13; I 2 = 24%) or the Hispanic population (OR = 1.08, 95% CI: 0.95, 1.23; I 2 = 0%), while they were associated with obesity in the Caucasian population (OR = 1.10, 95% CI: 1.04, 1.15; I 2 = 72%) ( Table 6 ). There were no significant differences in the association between the 3 ethnicity subgroups (P = 0.43). This lack of association might be due to the low number of studies carried out in Asian or Hispanic populations (n ≤ 4), the relatively small cohort sizes, or differences in cohort characteristics as compared with the Caucasian cohorts. In both ethnic groups, adult cohorts and childhood cohorts were present with comparable age ranges. However, most Asian studies contained only grade I obesity patients, in contrast to Caucasian cohorts, in which all levels of obesity severity were represented.
Meta-analyses of the association of PCSK1 SNPs with quantitative traits
The PCSK1 SNPs investigated here have mostly been associated with severe obesity, but they have not been identified in genome-wide association studies for BMI. Therefore, we investigated the contribution of these SNPs to quantitative traits (BMI and WC) (Web Figure 4) . The association of rs6232 with BMI was weak (β = 0.06, 95% CI: −0.00, 0.12). Similarly, rs6234-rs6235 was only weakly associated with increased BMI (β = 0.02, 95% CI: 0.01, 0.03), yet significantly so. The heterogeneity within both meta-analyses was low (I 2 = 15% and I 2 = 1% for rs6232 and rs6234-rs6235, respectively). The meta-analysis of the limited number of studies reporting on WC showed that there was no significant association of rs6232 with increased WC (β = 0.37, 95% CI: −0.00, 0.75) (Web Figure 4) . However, the SNP pair rs6234-rs6235 was significantly associated with WC (β = 0.24, 95% CI: 0.07, 0.41). For rs6234-rs6235, the SNP was more strongly associated with WC than with BMI. Because not all of the studies that reported on BMI also reported on WC, we investigated whether this could be a subgroup effect. We analyzed the associations with BMI and WC within the subgroup of cohort studies that reported on both WC and BMI. The association of rs6234-rs6235 with WC remained stronger than the association with BMI (BMI: β = 0.04, 95% CI: −0.02, 0.11; WC: β = 0.24, 95% CI: 0.07, 0.41; P = 0.03).
Sensitivity analysis
The influence of studies prone to bias was investigated using 2 meta-analyses. First, we conducted a sensitivity analysis by excluding the studies that were appraised to be most prone to bias and those that did not report on HardyWeinberg equilibrium (Table 5 ; Web Table 1 ). Almost all results were robust to the sensitivity analysis for Dušátková et al. (46) and Xi et al. (30) . However, the sensitivity analysis did yield a significant difference in the association of rs6234-rs6235 with obesity between childhood cohorts and adult cohorts (P = 0.005). In addition, heterogeneity (I 2 ) within childhood cohorts was reduced to 30%, versus 78% before. The significant difference between childhood and adult cohorts in the association of rs6232 with obesity was reduced by removing the study by Dušátková et al. (46) (P = 0.07). In a second sensitivity analysis, the Swiss cohort described by Meyre et al. (31) was replaced by the Swiss cohort described by Benzinou et al. (22) (see above). The implications of the sensitivity analysis for the Swiss adult cohort were discussed above (Web Table 2 ).
Credibility of cumulative evidence
Using the Venice guidelines for rating cumulative epidemiologic evidence, we assessed the credibility of the results (44) ( Table 6 ). For rs6232, only the subgroup analysis for grade I obesity was considered to have produced strong epidemiologic evidence ("A"). The subgroup analysis for grade III obesity received a "C" rating, because there was high heterogeneity and the results were not robust to sensitivity analyses. The other analyses were rated as showing moderate epidemiologic evidence ("B"). Quantitative-trait analyses received a "B" rating for replication because of the low number of studies, resulting in an overall "B" rating for cumulative evidence. For rs6234-rs6235, subgroup analyses for adults, grade I obesity, and grade II obesity were considered to provide strong epidemiologic evidence ("A"). Childhood and ethnic subgroup analyses were considered to provide weak epidemiologic evidence ("C"). Other analyses were rated as providing moderate ("B") epidemiologic evidence.
DISCUSSION
This meta-analysis combined data from 38 study cohorts from 19 studies and comprised data on more than 200,000 participants. The cumulative epidemiologic evidence was moderate for the general meta-analysis and strong for obesity grade I subgroup analyses. The cumulative epidemiologic evidence was particularly weak for Asian, obesity grade III, and childhood subgroup analyses.
A significant association of the PCSK1 SNPs rs6232 and rs6234-rs6235 with obesity was demonstrated. Furthermore, we showed for the first time (to our knowledge) that the association of PCSK1 rs6232 with obesity is stronger in childhood cohorts than in adult cohorts. After exclusion of 2 studies, we observed a similar significant difference for rs6234-rs6235.
A nominal association with BMI was found for rs6234-rs6235, but more importantly we showed for the first time that rs6234-rs6235 contributes more to WC than to BMI. These findings suggest that PCSK1 polymorphisms predispose some people to central obesity, which leads to an increased risk of cardiovascular disease and type 2 diabetes. In a large metaanalysis, Heid et al. (50) showed that the genetic regulation of body fat distribution is distinct from heritability of BMI or obesity risk. Only a minority of genetic association studies use WC as a measure of obesity, although evidence shows that WC and waist:height ratio correlate better with diabetes, hypertension, and cardiovascular disease (51) .
The case-control study design enriches the sample for severe cases and is therefore more sensitive to finding associations (48) . This is demonstrated by the strong association of PCSK1 SNPs with obesity versus the weak association with BMI in this meta-analysis and in previous reports (27, 28, 31) . In this meta-analysis, we tested whether the association of the PCSK1 SNPs rs6232 and rs6234-rs6235 with obesity correlated with obesity severity, but we found only limited evidence for rs6234-rs6235.
The increased prevalence of childhood obesity is a hallmark of the current obesity epidemic. It is generally accepted that obese children have a 50%-70% increased risk of being obese in adulthood (52) . Furthermore, heritability of BMI varies with age. At birth, heritability is as low as 24%; it increases throughout childhood to 55% at 1 year of age and up to 70% or more during adolescence, while the genetic effect on BMI in adults is estimated to be approximately 55%-85% (53, 54) . This increased inheritance during puberty could be explained by the fact that persons with increased susceptibility might seek out obesogenic environments (55) . Increased inheritance has been observed in other traits and attributed to gene-environment interaction (56) (57) (58) . Gene-specific differences in inheritance patterns have been shown for variations in the fat mass and obesity-associated gene (FTO) (55) . However, to our knowledge, the question of whether gene expression alters with age has not been investigated for either FTO or any other gene. In this study, subgroup analyses of childhood obesity versus adult obesity showed that rs6232 was significantly more strongly associated with childhood obesity. The same was true for rs6234-rs6235 within the context of a sensitivity analysis.
Since the recognition of the obesity epidemic by the WHO in 1997, the definition of BMI cutoff points for clinical obesity in different populations has been much debated (1, 33, 34, 59) . It is widely recognized that Asian and Hispanic populations have increased risks of cardiovascular disease and type 2 diabetes at lower BMIs than Caucasian populations. This risk difference can be attributed to cultural, economic, geographical, and genetic differences. This study assessed the association of PCSK1 SNPs with obesity in different populations. PCSK1 rs6234-rs6235 was shown to be associated with obesity in Caucasians but not in Asians or Hispanics.
Our meta-analysis also included cohorts of African-American descent, but there were too few cohorts for us to perform any analysis. The lack of associations was largely due to the lack of a sufficient number and size of studies for these ethnic groups.
PC1/3, the gene product of PCSK1, is expressed in neuronal and endocrine cells, in which it cleaves and hence activates a variety of prohormones and proneuropeptides. Besides their implications for feeding behavior and thermogenesis, the PCSK1 SNPs rs6232 and rs6234-rs6235 have also been associated with differences in glucose homeostasis, proinsulin disorders, fat oxidation, and postabsorptive resting energy expenditure (4-10). Since 1997, several patients with congenital PCSK1 deficiency have been identified (2, (11) (12) (13) (14) (15) (16) . Recently, patients who are heterozygous for nonsynonymous mutations in PCSK1 have been identified, which shows that PCSK1 mutations can cause obesity in a dominant manner (60, 61) . Remarkably, several of these variants have been found to have only mild functional effects on PC1/3 activity in vitro. It remains unclear how PCSK1 SNPs contribute to obesity and to what extent environmental factors might be important. The use of mouse models might be instrumental in addressing these questions. To date, 2 mouse models for PC1/3 deficiency are available (62, 63) . The Pcsk1-null mouse displays a growth retardation phenotype, due to impaired processing of pro-growth-hormone-releasing hormone (62) . However, the Pcsk1-null mice were not reported to be obese. In another mouse model, mice harboring the Pcsk1-p.Asn222Asp mutation do become obese (63) . Interestingly, the amino acid change of asparagine at position 222 is the neighboring amino acid of PCSK1-p.Asn221Asp (encoded by rs6232) in human PC1/3. Recently, it has been shown in vitro that mouse PC1/3-p.Asn222Asp is defectively transported from the endoplasmic reticulum compartment (64) . Research aimed at obesity pathogenesis in this model might yield interesting therapeutic avenues for treatment of PCSK1-related human obesity.
In addition to the SNPs investigated in this study, 2 other SNPs in close proximity to PCSK1 have been identified as contributing to obesity phenotypes. The SNP rs2570467 has been found to be mildly associated with WC in populations of African ancestry (29) , and rs261967 has been identified as being associated with BMI at the genome-wide level in East Asians (21) . Interestingly, both SNPs are located in a transcript antisense to PCSK1 exons and might regulate PCSK1 expression.
This study was limited by the assumption that the genetic risk of PCSK1 SNPs is additive and by the fact that no corrections were made for multiple testing. Although we feel it was justified, our choice of random-effects models to calculate summary effects for the association was conservative and reduced the statistical power of the tests. This was exemplified by the nonsignificant associations for obesity grade II and grade III cohorts, whereas Berndt et al. (32) found significant associations for all obesity classes in their meta-analysis.
This study had good statistical power (>97%) to find the overall association, but the study was limited by the low power in certain subgroups, such as the Asian, childhood (6 cohorts), and obesity grades II and III subgroups (10%-40%). Since the effect sizes for the association of PCSK1 SNPs with obesity were relatively small (OR = 1.10), it is important to conduct more studies for these subgroups. To date, most of the available genetic information pertains to the Caucasian population, but there is also increasingly information available for the Asian population. Genetic association studies in Hispanic and ( particularly) African populations are scarce. We recommend that more good-quality studies be conducted in these populations.
In conclusion, the current meta-analysis showed a mild but significant contribution of the PCSK1 SNPs rs6232 and rs6234-rs6235 to the genetic predisposition to obesity in an age-and ethnicity-dependent fashion. In addition, we demonstrated that rs6234-rs6235 is more strongly associated with WC than with BMI, which sheds new light on PCSK1-related obesity.
